SIP 1
|
Air Travel and Pregnancy
|
SIP 2
|
Umbilical Cord Blood Banking
|
SIP 6
|
Alternatives to HRT for the Management of Symptoms of The Menopause
|
SIP 7
|
Progress in Cervical Screening in the UK
|
SIP 8
|
Perinatal Risks associated with IVF
|
SIP 12
|
Targeted Therapies for the Management of Ovarian Cancer
|
SIP 13
|
Metformin Therapy for the Management of Infertility in Women with Polycystic Ovary Syndrome
|
SIP 14
|
Clamping of the Umbilical Cord and Placental Transfusion
|
SIP 15
|
Non-invasive Prenatal Testing for Chromosomal Abnormality using Maternal Plasma DNA
|
SIP 17
|
Bariatric Surgery in Improving Reproductive Health, The Role of
|
SIP 21
|
Reproductive Outcomes after Local Treatment for Preinvasive Cervical Disease
|
SIP 24
|
Reproductive Aging
|
SIP 25
|
Ovarian Cancer, Optimum Surgery in Advanced-stage
|
SIP 29
|
Magnesium Sulphate to Prevent Cerebral Palsy following Preterm Birth
|
SIP 30
|
Acupuncture and Chinese Herbal medicine for women with chronic pelvic pain
|
SIP 32
|
Endometrial Cancer in Obese women
|
SIP 33
|
Preterm Labour, Antibiotics and Cerebral Palsy
|
SIP 34
|
Induction of Labour at Term in Older Mothers
|
SIP 35
|
Fertility-sparing Treatments in Gynaecological Cancers
|
SIP 36
|
Enhanced Recovery in Gynaecology
|
SIP 37
|
Chemical Exposures During Pregnancy
|
SIP 38
|
Stem Cell Therapies in Obstetrics and Gynaecology
|
SIP 39
|
Adhesion Prevention Agents in Obstetrics and Gynaecology
|
SIP 40
|
Sex Steroid Treatment for Pubertal Induction and Replacement in the adolescent Girl
|
SIP 41
|
Perinatal Management of Pregnant Women at the Threshold of Infant Viability– the Obstetric Perspective
|
SIP 42
|
Botulinum Toxin for an overactive Bladder
|
SIP 43
|
Vitamin D in Pregnancy
|
SIP 44
|
High-grade Serous Carcinomas, The Distal Fallopian Tube as the Origin of Non-uterine Pelvic
|
SIP 45
|
Ascites in Ovarian Cancer Patients, Management of
|
SIP 46
|
Chronic Pelvic Pain Relief, Therapies Targeting the Nervous System for
|
SIP 48
|
Genetic Predisposition to Gynaecological Cancers, Management of Women with a
|
SIP 49
|
Ultrasound from Conception to 10+0 Weeks of Gestation
|
SIP 50
|
Developing New Pharmaceutical Treatments for Obstetric Conditions
|
SIP 51
|
Sentinel Lymph Node Biopsy in Endometrial Cancer
|
SIP 52
|
Management of Female Malignant Ovarian Germ Cell Tumours
|
SIP 53
|
The Role of Natural Killer Cells in Human Fertility
|
SIP 54
|
Local Endometrial Trauma (Endometrial Scratch): A Treatment Strategy to Improve Implantation Rates
|
SIP 55
|
The Effect of Surgery for Endometriomas on Fertility
|
SIP 56
|
Congenital Cytomegalovirus Infection: Update on Treatment
|
SIP 57
|
Epigenetics and Reproductive Medicine
|
SIP 58
|
Diagnostic Biomarkers for Predicting Adverse Early Pregnancy Outcomes
|
SIP 59
|
Antenatal and Postnatal Analgesia
|
SIP 60
|
The Combined Use of USG and Fetal MRI for Comprehensive Fetal Neurological Assessment in Fetal Congenital Cardiac Defects
|
SIP 61
|
Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT)
|
SIP 62
|
Reproductive Implications and Management of Congenital Uterine Anomalies
|
SIP 63
|
Elective Egg Freezing for Non-Medical Reasons
|
SIP 64
|
Clinical Utility of Prenatal Exam Sequencing in Evaluation of Fetus with Congenital Anomalies
|
SIP 65
|
Uterine Transplantation
|
SIP 66
|
Risk-Reducing Salpingo-oophorectomy & Use of HRT below the Age of Natural Menopause
|
SIP 67
|
Understanding the relationship between social determinants of health and maternal mortality
|
SIP 68
|
Evaluating misoprostol and mechanical methods for induction of labour
|
SIP 69
|
The use of Biomarkers to Stratify Surgical Care in Women with Ovarian Cancer
|
SIP 70
|
Subclinical hypothyroidism and antithyroid autoantibodies in women with subfertility or recurrent pregnancy loss
|
SIP 71
|
Robotic surgery in gynaecology
|
SIP 72
|
Laser treatment for genitourinary syndrome of menopause
|
SIP 73
|
Management of Impacted Fetal Head at Caesarean Birth
|
No comments:
Post a Comment